Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - OMEROS CORPFinancial_Report.xls
10-Q - 10-Q - OMEROS CORPomer-2013930x10q.htm
EX-12.1 - RATIO OF EARNINGS TO FIXED CHARGES - OMEROS CORPexhibit1212013930.htm
EX-31.2 - CERTIFICATION 302 OF FINANCIAL OFFICER - OMEROS CORPomer-ex312_2013930xq3.htm
EX-31.1 - CERTIFICATION 302 OF PRINCIPAL EXECUTIVE OFFICER - OMEROS CORPomer-ex311_2013930xq3.htm
EX-10.1 - SEVENTH AMENDMENT TO OXFORD LOAN AND SECURITY AGREEMENT - OMEROS CORPexhibit101seventhamendment.htm
EX-10.2 - FORM OF STOCK OPTION AWARD AGREEMENT UNDER THE 2008 EQUITY INCENTIVE PLAN - OMEROS CORPexhibit102formofoptiongran.htm
EX-32.2 - CERTIFICATION 906 OF FINANCIAL OFFICER - OMEROS CORPomer-ex322_2013930xq3.htm


Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Omeros Corporation (the “Company”) for the quarter ended September 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.
 
 
Dated: November 7, 2013
 
 
 
/s/ Gregory A. Demopulos
 
Gregory A. Demopulos, M.D.
 
Principal Executive Officer